<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Microbiol</journal-id><journal-title>BMC Microbiology</journal-title><issn pub-type="epub">1471-2180</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2180-2-26</article-id><article-id pub-id-type="pmid">12241561</article-id><article-id pub-id-type="doi">10.1186/1471-2180-2-26</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>HIV-1 expression induces cyclin D<sub>1</sub> expression and pRb phosphorylation in infected podocytes: cell-cycle mechanisms contributing to the proliferative phenotype in HIV-associated nephropathy</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Nelson</surname><given-names>Peter J</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>peter.nelson@mssm.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Sunamoto</surname><given-names>Masaaki</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>masaaki.sunamoto@mssm.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Husain</surname><given-names>Mohammad</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>mohammad.husain@mssm.edu</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Gelman</surname><given-names>Irwin H</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>irwin.gelman@mssm.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Division of Nephrology, Mount Sinai School of Medicine, New York, NY, 10029, USA</aff><aff id="I2"><label>2</label>Division of Infectious Diseases, Mount Sinai School of Medicine, New York, NY, 10029, USA</aff><pub-date pub-type="collection"><year>2002</year></pub-date><pub-date pub-type="epub"><day>19</day><month>9</month><year>2002</year></pub-date><volume>2</volume><fpage>26</fpage><lpage>26</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2180/2/26"/><history><date date-type="received"><day>18</day><month>7</month><year>2002</year></date><date date-type="accepted"><day>19</day><month>9</month><year>2002</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2002 Nelson et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement><copyright-year>2002</copyright-year><copyright-holder>Nelson et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder></permissions><abstract><sec><title>Background</title><p>The aberrant cell-cycle progression of HIV-1-infected kidney cells plays a major role in the pathogenesis of HIV-associated nephropathy, however the mechanisms whereby HIV-1 induces infected glomerular podocytes or infected tubular epithelium to exit quiescence are largely unknown. Here, we ask whether the expression of HIV-1 genes in infected podocytes induces cyclin D<sub>1</sub> and phospho-pRb (Ser780) expression, hallmarks of cyclin D1-mediated G<sub>1</sub> &#x02192; S phase progression.</p></sec><sec><title>Results</title><p>We assessed cyclin D<sub>1</sub> and phospho-pRb (Ser780) expression in two well-characterized models of HIV-associated nephropathy pathogenesis: HIV-1 infection of cultured podocytes and HIV-1 transgenic mice (Tg26). Compared to controls, cultured podocytes expressing HIV-1 genes, and podocytes and tubular epithelium from hyperplastic nephrons in Tg26 kidneys, had increased levels of phospho-pRb (Ser780), a target of active cyclin D<sub>1</sub>/cyclin-dependent kinase-4/6 known to promote G<sub>1</sub> &#x02192; S phase progression. HIV-1-infected podocytes showed markedly elevated cyclin D<sub>1</sub> mRNA and cyclin D<sub>1</sub> protein, the latter of which did not down-regulate during cell-cell contact or differentiation, suggesting post-transcriptional stabilization of cyclin D<sub>1</sub> protein levels by HIV-1. The selective suppression of HIV-1 transcription by the cyclin-dependent kinase inhibitor, flavopiridol, abrogated cyclin D<sub>1</sub> expression, underlying the requirement for HIV-1 encoded products to induce cyclin D<sub>1</sub>. Indeed, HIV-1 virus deleted of <italic>nef</italic> failed to induce cyclin D<sub>1</sub> mRNA to the level of other single gene mutant viruses.</p></sec><sec><title>Conclusions</title><p>HIV-1 expression induces cyclin D<sub>1</sub> and phospho-pRb (Ser780) expression in infected podocytes, suggesting that HIV-1 activates cyclin D1-dependent cell-cycle mechanisms to promote proliferation of infected renal epithelium.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Proliferation and dedifferentiation of HIV-1 infected renal epithelium is singularly unique compared to the effects of HIV-1 infection in other non-lymphoid tissues. Indeed, unlike the atrophy and cell-death of infected central nervous system [<xref ref-type="bibr" rid="B1">1</xref>], cardiac [<xref ref-type="bibr" rid="B2">2</xref>], or gastro-intestinal [<xref ref-type="bibr" rid="B3">3</xref>] parenchyma, aberrant cell-cycle progression of infected renal epithelium is a defining feature of HIV-associated nephropathy (HIVAN) [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Yet, the mechanisms are largely unknown whereby HIV-1 subverts the cell-cycle controls that normally maintain renal epithelial in G<sub>0</sub>. Nonetheless, several observations from <italic>in vitro</italic> and <italic>in vivo</italic> models of HIVAN pathogenesis suggest that HIV-1 expression itself may be a key pathogenic factor. Infection of cultured podocytes with replication incompetent HIV-1 demonstrated that HIV-1 gene expression leads to the proliferation and dedifferentiation of the infected podocytes [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>], recapitulating the phenotypes observed in HIVAN specimens [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. Similarly, renal expression of replication incompetent HIV-1 proviral transgenes in mice and rats produces a proliferative renal lesion that is indistiguisable both histopathologically and clinically from human HIVAN [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B14">14</xref>]. These observations raise the possibility that HIV-1 gene products may interact with mitogenic pathways in infected renal epithelium to cause aberrant cell-cycle engagement.</p><p>In comparison to the two general alternative mechanisms utilized by known transforming viruses to promote cell-cycle progression, namely, by activating or bypassing endogenous D-type cyclins (herein, referred to as "cyclin D"), it has not been established whether HIV-1 gene products trigger either cyclin D-dependent or cyclin D-independent proliferation in non-lymphoid tissues [<xref ref-type="bibr" rid="B15">15</xref>]. In infected renal epithelium, HIV-1 could disrupt the inhibitory binding of pRb to E2F independent of endogenous cyclin D, analogous to transforming viral mechanisms that bypass and down-regulate endogenous cyclin D, such as SV-40 T antigen binding to pRb [<xref ref-type="bibr" rid="B16">16</xref>], HHV-8 <italic>v</italic>-cyclin binding to and activating cyclin-dependent kinase-6 (CDK) [<xref ref-type="bibr" rid="B17">17</xref>], and activation of cyclin E by EBV-induced <italic>c</italic>-myc [<xref ref-type="bibr" rid="B18">18</xref>]. Alternatively, HIV-1 could activate cyclin D-dependent proliferation, as exemplified by RSV <italic>v</italic>-src-mediated signaling [<xref ref-type="bibr" rid="B19">19</xref>]. In most tissues, the selective activation of these cell-cycle pathways is readily discernable. Indeed, if cells depend on cyclin D-mediated G1 &#x02192; S transition, passage from G<sub>0</sub> through the restriction point in G<sub>1</sub> is dependent on the <italic>de novo</italic> expression of cyclin D transcript, accumulation of nuclear cyclin D protein, and cyclin D/CDK-4/6 phosphorylation of pRb [<xref ref-type="bibr" rid="B20">20</xref>]. Then, although nuclear-localized cyclin D decreases in S phase in individual cells [<xref ref-type="bibr" rid="B21">21</xref>], total cyclin D in asynchronously proliferating cell populations remain elevated compared to quiescent cells [<xref ref-type="bibr" rid="B20">20</xref>]. In renal epithelial and mesenchymal cells, cyclin D<sub>1</sub> is the dominant D-type cyclin activated during cell-cycle progression, both during nephrogenesis [<xref ref-type="bibr" rid="B22">22</xref>] and in non-viral-mediated kidney cell proliferation [<xref ref-type="bibr" rid="B23">23</xref>].</p><p>Here, we ask whether infected podocytes expressing HIV-1 genes show the hallmarks of cyclin D<sub>1</sub>-dependent proliferation, specifically the up-regulation of cyclin D<sub>1</sub> transcript and protein expression and the subsequent phosphorylation of pRb on serine 780, a target site of active cyclin D<sub>1</sub>/CDK-4/6 that is not shared with cyclin E/CDK-2 complexes [<xref ref-type="bibr" rid="B24">24</xref>]. Utilizing two well-characterized models of HIVAN pathogenesis, HIV-1 transgenic mice [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref>] and HIV-1 infection of cultured podocytes [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>] we find not only these hallmarks of cyclin D<sub>1</sub>-dependent proliferation, but also dysregulation of cyclin D<sub>1</sub> expression that normally occurs with cell-cell contact and differentiation [<xref ref-type="bibr" rid="B25">25</xref>].</p></sec><sec><title>Results</title><sec><title>Phospho-pRb (Ser780) expression in vivo</title><p>Cyclin D<sub>1</sub> is characterized as the major D-type cyclin controlling G<sub>1</sub>-phase progression in kidney cells, both during normal and abnormal proliferation [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B23">23</xref>]. To determine whether cyclin D<sub>1</sub> may be active in promoting G<sub>1</sub> &#x02192; S progression in kidneys expressing HIV-1 genes, we utilized a well-characterized HIV-1 transgenic mouse model (Tg26) of HIVAN [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. Secondary to renal expression of the HIV-1 NL4-3 &#x00394;<italic>gag-pol</italic> proviral transgene, adolescent Tg26 transgenics develop a progressive, proliferative renal disease marked by podocyte and tubular epithelial hyperplasia that is indistinguishable both clinically and histopathologically from human HIVAN. In order to determine if cyclin D<sub>1</sub> plays a role in this hyperplasia, kidneys from three proteinuric 40-day old transgenic siblings and three non-transgenic littermates were stained by immunohistochemistry with antibody to phospho-pRb (Ser780), a site of cyclin D<sub>1</sub>/CDK-4/6 phosphorylation not targeted by cyclin E/CDK-2 complexes that disrupts pRb/E2F binding for G<sub>1</sub> &#x02192; S progression [<xref ref-type="bibr" rid="B24">24</xref>]. Figure <xref ref-type="fig" rid="F1">1</xref> depicts the intense, heterogeneous nuclear staining of glomerular podocytes and tubular epithelium from hyperplastic nephrons in the diseased transgenics versus the absent staining of nephrons in the non-transgenics consistent with the very low mitotic index in normal kidneys of adult animals [<xref ref-type="bibr" rid="B26">26</xref>]. This suggests that cyclin D<sub>1</sub> is promoting cell-cycle progression during the proliferation of epithelium in diseased kidneys.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold><italic>In situ</italic> immunodetection of phosphorylated serine 780 on pRb in Tg26 kidneys.</bold> Phospho-pRb (Ser780) is not detected in the nuclei of epithelium of normal kidneys (<bold>A</bold>), but is readily detected in podocytes (short arrows) and tubular epithelial cells (long arrows) in hyperplastic nephrons of diseased transgenic kidneys at cortical (<bold>B)</bold>, juxta-medullary (<bold>C</bold>), and medullary (<bold>D</bold>) depths. The prominent staining in many, but not all nuclei, is characteristic of asynchronously proliferating cells. (magnification = 40&#x000d7;)</p></caption><graphic xlink:href="1471-2180-2-26-1"/></fig></sec><sec><title>Cyclin D<sub>1</sub> and phospho-pRb (Ser780) expression in vitro</title><p>HIV-1 expression in cultured podocytes recapitulates the phenotypic abnormalities induced by HIV-1 expression in infected podocytes <italic>in vivo,</italic> specifically proliferation, loss of contact-mediated growth control, and dedifferentiation [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. To determine if these phenotypes were marked by enhanced cyclin D<sub>1</sub> and phospho-pRb (Ser780) expression, we utilized the podocyte cell-culture protocol developed by Rieser et al. [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>] to study both sub-confluent podocyte growth and podocyte growth during the formation of mature cell-cell contacts at confluence. In this protocol, normal podocytes are growth-arrested 4&#x02013;5 days after initial confluence and are fully differentiated with mature cell-cell contacts approximately 10 days later. Figure <xref ref-type="fig" rid="F2">2A</xref> shows that cyclin D<sub>1</sub> message levels are nearly equivalent between mock ("wild-type")-, control virus-, and HIV-1-infected subconfluent podocytes, although only the HIV-1-infected subconfluent podocytes had elevated levels of cyclin D<sub>1</sub> protein. In contrast, cell-cell contact in wild-type and control-infected, but not HIV-1-infected podocytes, caused a severe down-regulation of cyclin D<sub>1</sub> transcript and protein concomitant with the up-regulation of synaptopodin, a podocyte differentiation marker [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B28">28</xref>], by the end of the 14-day differentiation period. Although HIV-1 infected podocytes showed some decrease in cyclin D<sub>1</sub> message by the end of the differentiation period, cyclin D<sub>1</sub> protein levels remained elevated, suggesting activation by HIV-1 of mechanisms that stabilize cyclin D<sub>1</sub> protein levels. Moreover, HIV-1-infected podocytes, but not control-infected podocytes, had readily detectable phospho-pRb (Ser780) at the end of the differentiation period, suggesting that the stably up-regulated cyclin D<sub>1</sub> protein remained active in promoting cell-cycle progression (Figure <xref ref-type="fig" rid="F2">2B</xref>). The ongoing proliferation of HIV-1-infected podocytes following cell-cell contact led to the formation of multiple foci (Figure <xref ref-type="fig" rid="F2">2C</xref>) with intense, heterogenous nuclear cyclin D<sub>1</sub> immunofluorescence consistent with ongoing asynchronous proliferation in this population of cells (Figure <xref ref-type="fig" rid="F3">3</xref>). These data indicate that HIV-1 expression in infected podocytes induces cyclin D<sub>1</sub> and phospho-pRb (Ser780) expression, hallmarks of cyclin D<sub>1</sub>-mediated G<sub>1</sub> &#x02192; S progression. The data, however, do not prove that cyclin D<sub>1</sub> expression alone is sufficient to cause cell-cycle progression.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Expression of cyclin D<sub>1</sub> and phospho-pRb (Ser780) in HIV-1-infected podocytes.</bold> (<bold>A</bold>) Northern and western blot detection of cyclin D<sub>1</sub> expression in wild-type, control-infected, and HIV-1-infected podocytes during subconfluent (SC) growth at 33&#x000b0;C and during 14 days of differentiation of confluent podocytes at 37&#x000b0;C shows that neither the cyclin D<sub>1</sub> transcript nor the elevated cyclin D<sub>1</sub> protein in HIV-1-infected podocytes (full-length, singly-spliced, and multiply spliced HIV-1 transcripts) are significantly down-regulated by podocyte cell-cell contact or by podocyte differentiation (synaptopodin transcript) when compared to wild-type or control-infected (one transcript from LTR sequences) podocytes. (<bold>B</bold>) Immunodetection of phospho-pRb (Ser780) on several phosphorylated forms (arrows) of pRb in the asynchronously proliferating, HIV-1-infected podocytes that is absent in the quiescent, control-infected podocytes after 14 days of differentiation at 37&#x000b0;C. (<bold>C</bold>) Abundant foci formation in confluent HIV-1-infected podocytes but not in confluent control-infected podocytes due to the ongoing proliferation of HIV-1-infected podocytes after cell-cell contact. Blots are representative of two independent experiments.</p></caption><graphic xlink:href="1471-2180-2-26-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Heterogenous nuclear localization of cyclin D<sub>1</sub> in HIV-1-infected podocytes.</bold> Immunofluorescent detection of nuclear cyclin D<sub>1</sub> in quiescent, wild-type podocytes after 14 days of differentiation at 37&#x000b0;C shows light speckled staining in all nuclei (<bold>A</bold>). This differs markedly from the intense nuclear staining of cyclin D<sub>1</sub> in some, but not all nuclei, of the asynchronously proliferating, HIV-1-infected podocytes (GFP positive podocytes) (<bold>B</bold> and <bold>C</bold>). (magnification = 100&#x000d7;)</p></caption><graphic xlink:href="1471-2180-2-26-3"/></fig></sec><sec><title>Requirement of HIV-1 expression for induction of cyclin D<sub>1</sub></title><p>We sought to further confirm that HIV-1 expression, and not some idiosyncratic effect of infection, was directly inducing cyclin D<sub>1</sub> expression in infected podocytes. First, we utilized the small molecule cyclin-dependent kinase inhibitor, flavopiridol, which at low concentrations (e.g., less than 100 nM) can selectively suppress HIV-1 transcript elongation without altering cellular transcripts in cell types of various lineages, including podocytes [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. Cyclin D<sub>1</sub> transcript levels were followed before, during, and after treatment of confluent wild-type or HIV-1 infected podocytes with 50 nM flavopiridol, a dose that suppresses HIV-1 transcription by 70% [<xref ref-type="bibr" rid="B7">7</xref>]. Analysis of HIV-1, cyclin D<sub>1</sub>, and glyceraldehyde-3-phosphate dehydrogenase (G3PDH) transcript levels in podocytes treated with flavopiridol for 2 days, followed by drug washout for 1 day, showed that cyclin D<sub>1</sub> expression paralleled HIV-1 expression in infected podocytes before, during and after suppression of HIV-1 genes (Figure <xref ref-type="fig" rid="F4">4</xref>). Secondly, we utilized single gene mutants of HIV-1 [<xref ref-type="bibr" rid="B8">8</xref>] to determine which HIV-1 gene(s) may be involved with up-regulating cyclin D<sub>1</sub> expression. Analysis of cyclin D<sub>1</sub> transcript levels in podocytes infected with HIV-1 singly mutated with premature stop codons in the genes encoding the various structural and regulatory proteins of HIV-1 (except <italic>tat</italic>, which is present in every virus) showed that <italic>nef</italic>-deficient virus did not significantly up-regulate cyclin D<sub>1</sub> expression when compared to the other mutant viruses (Figure <xref ref-type="fig" rid="F5">5</xref>). Taken together, these data indicate that induction of cyclin D<sub>1</sub> expression requires HIV-1 gene expression and that HIV-1 <italic>nef</italic> is important for this induction.</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Parallel expression of HIV-1 and cyclin D<sub>1</sub>.</bold> Northern blot de tection of HIV-1, cyclin D<sub>1</sub>, and G3PDH transcripts before (day 14), during (two days with drug, day 16), and after (one day after drug washout, day 17) treatment of wild-type and HIV-1-infected podocytes with 50 nM flavopiridol, a small molecule CDK inhibitor of HIV-1 transcription, showing that cyclin D<sub>1</sub> expression parallels HIV-1 expression. Blot is representative of two independent experiments.</p></caption><graphic xlink:href="1471-2180-2-26-4"/></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Mapping of HIV-1 genes that induce cyclin D<sub>1</sub> expression.</bold> Northern blot detection of cyclin D<sub>1</sub> and G3PDH transcripts from wild-type, control-infected, and HIV-1-infected podocytes infected with single gene mutants of HIV-1 (<italic>tat</italic> present in every virus). Similar to wild-type and control-infected podocytes, podocytes infected with <italic>nef</italic>-deficient HIV-1 do not significantly up-regulated cyclin D<sub>1</sub> expression compared to podocytes infected with other single gene mutant viruses.</p></caption><graphic xlink:href="1471-2180-2-26-5"/></fig></sec></sec><sec><title>Discussion</title><p>The mechanisms whereby HIV-1 subverts cell-cycle controls in infected renal epithelium have been unclear. Here, we demonstrate that podocytes expressing HIV-1 genes display the hallmarks of cyclin D<sub>1</sub>-dependent cell-cycle progression, specifically, that cyclin D<sub>1</sub> transcript and protein expression are markedly up-regulated, and that levels of phospho-pRb (Ser780), a target of cyclin D<sub>1</sub>/CDK-4/6 but not cyclin E/CDK-2 complexes [<xref ref-type="bibr" rid="B24">24</xref>], are induced <italic>in vitro</italic> and <italic>in vivo.</italic> In addition, preliminary micro-array gene profiling of HIV-1-infected tubular epithelium showed that cyclin D<sub>1</sub> expression is up-regulated several fold when compared to uninfected tubular epithelium (Michael Ross, personal communication). This suggests that the HIV-1-induced proliferation of infected renal epithelium may be caused by a cyclin D<sub>1</sub>-dependent mechanism, unlike other viruses that bypass a requirement for G<sub>1</sub>-phase cyclins to trigger aberrant cell-cycle progression. Moreover, normal cellular controls on cell-cycle progression appears to be dysregulated by HIV-1 expression because cell-cell contact and differentiation, events that normally lead to the down-regulation of cyclin D<sub>1</sub> expression [<xref ref-type="bibr" rid="B25">25</xref>], did not significantly alter cyclin D<sub>1</sub> protein levels in HIV-1 infected podocytes. This suggests a novel stabilization of cyclin D<sub>1</sub> protein in podocytes by HIV-1. We are exploring whether this occurs from enhanced translation of cyclin D<sub>1</sub> message and/or decreased degradation of cyclin D<sub>1</sub> protein and whether other D-type cyclins may be involved in phosphorylating pRb in HIVAN.</p><p>Prior studies in HIV-1 transgenic animals support the model that HIV-1 gene products interact with endogenous mitogenic pathways in infected renal epithelium. [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B14">14</xref>]. Kidney transplants between normal and transgenic Tg26 siblings suggested that specific HIV-1 proteins within the kidney, and not circulating factors, transform infected renal epithelium [<xref ref-type="bibr" rid="B13">13</xref>]. Indeed, HIV-1 transgenic mice generated with an HIV-1 proviral construct mutated in the Nef "PXXP" SH3-binding motif for Src-family kinases failed to develop nephropathy [<xref ref-type="bibr" rid="B31">31</xref>], and a recent <italic>in vitro</italic> analysis of podocytes infected with single gene mutants of HIV-1 further suggest that Nef plays a central role in causing the proliferative phenotype in HIVAN [<xref ref-type="bibr" rid="B8">8</xref>]. Utilizing these same single gene mutant viruses, we showed here that Nef appears to be play a role in the up-regulation of cyclin D<sub>1</sub> by HIV-1 <italic>in vitro</italic>. Importantly, these single gene mutants do not exclude the possibility that other HIV-1 gene(s) may cooperate with <italic>nef</italic> to induce cyclin D1, particularly <italic>tat</italic>, which is present in every virus. Cumulatively, however, these observations do suggest a mechanism whereby HIV-1 expression in renal epithelium may induce cyclin D<sub>1</sub>: activation of Src-family kinases by Nef would be expected to up-regulate cyclin D<sub>1</sub> gene expression and promote the synthesis and stabilization of cyclin D<sub>1</sub> protein via Src-Ras-MAPK and Src-PI3K-mTOR signal transduction pathways, respectively [<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B34">34</xref>]. Interestingly, our unpublished <italic>in vitro</italic> observations and published data showing marked expression of basic fibroblast growth factor in the interstitium of HIVAN kidneys [<xref ref-type="bibr" rid="B35">35</xref>] suggest that soluble mitogens may be important cofactors with HIV-1 expression to induce cyclin D<sub>1</sub>. Thus, interrupting HIV-1 gene expression should down-regulate cyclin D<sub>1</sub> and correct the phenotypic abnormalities in infected podocytes. In support of this notion, we show here that cyclin D<sub>1</sub> expression parallels HIV-1 expression before, during, and after suppression of HIV-1 transcription with flavopiridol, and recently, we showed that longer periods of treatment with flavopiridol ameliorate the phenotypic abnormalities of infected podocytes [<xref ref-type="bibr" rid="B7">7</xref>].</p></sec><sec><title>Conclusions</title><p>The following results of this study suggest that HIV-1 expression leads to cyclin D<sub>1</sub>-mediated G<sub>1</sub> &#x02192; S progression in infected podocytes: cyclin D<sub>1</sub> transcript and protein levels are markedly up-regulated, phospho-Rb (Ser780) levels are increased, cyclin D<sub>1</sub> protein and phospho-Rb (Ser780) levels do not decrease with podocyte cell-cell contact and differentiation, and the up-regulation of cyclin D<sub>1</sub> requires the expression of HIV-1 genes, particularly HIV-1 <italic>nef.</italic> In sum, these results suggest HIV-induced cell-cycle mechanisms may contribute to aberrant epithelial proliferation in HIVAN.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Podocyte cell culture and infection</title><p>Murine podocytes immortalized with interferon-inducible temperature-sensitive SV-40 T antigen (<italic>ts</italic>-SV-40 T) were isolated and infected with replication incompetent GFP-expressing HIV-1 virus, replication incompetent GFP-expressing single-gene mutants of HIV-1, or replication incompetent GFP-expressing control lentivirus containing GFP but no HIV-1 genes as previously described [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. In all cases, 70% to 80% of podocytes showed GFP expression 4 days post infection (data not shown). Podocytes were used before passage twenty and maintained in RPMI 1640 (Life Technologies) supplemented with 10% fetal calf serum, 1 &#x000d7; PenStrep (Life Technologies), and 20 U/ml recombinant interferon-gamma (Life Technologies) at 33&#x000b0;C. Unless otherwise indicated, all studies were conducted at cell confluency and 14 days after inactivation of <italic>ts</italic>-SV-40 T at the non-permissive temperature (37&#x000b0;C) when wild-type podocytes are fully differentiated [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>].</p></sec><sec><title>Immunohistochemistry</title><p>Kidneys from three 40 day-old Tg26 heterozygous transgenic siblings demonstrating 2+ proteinuria (Chemstrip 2GP, Roche) and three of their non-transgenics littermates were collected in accordance with Animal Use and Care Committee guidelines, fixed (10% buffered formalin), then paraffin-embedded (Department of Pathology, Mount Sinai School of Medicine). Four micron full coronal kidney sections from each animal were adhered to lysine-coated slides and used for immunodetection of phospho-Rb (Ser780) as follows: sections were deparaffinized and hydrated by placing in xylene for 8 minutes, followed by 3 minutes each of 100%, 96%, 80%, 70%, 50%, 30% ethanol, ending with 10 minutes in water; sections then underwent antigen retrieval (Glyca Reagent, Biogenex) followed by immunodetection (Super Sensitive Detection Kit, Biogenex) of phospho-Rb (Ser780) after a 12 hour incubation with a 1:1000 dilution of rabbit anti-phospho-Rb (Ser780) antibody (Cell Signaling) or control rabbit anti-sera (Biogenex) at 4&#x000b0;C.</p></sec><sec><title>Immunofluorescence</title><p>Following the 14 day podocyte differentiation protocol on coverslips to establish mature podocytes, wild-type and HIV-1 infected podocytes underwent immunofluorescent detection of cyclin D<sub>1</sub> as follows: coverslips were washed three times with 1 &#x000d7; PBS, fixed in 60% acetone/3.7% formaldehyde at -20&#x000b0;C for 20 minutes, then washed twice with 1 &#x000d7; PBS; the coverslips where then incubated with a 1:200 dilution of rabbit anti-cyclin D<sub>1</sub> antibody (Santa Cruz Biotechnology) or control rabbit sera (Biogenex) for 2 hours at room temperature followed by three washes with 1 &#x000d7; PBS; the coverslips were then incubated with a 1:250 dilution of rhodamine-labeled donkey-anti-rabbit anti-sera (Chemicon) for 45 minutes to detect the primary antibody; following three final washes with 1 &#x000d7; PBS, the coverslips were mounted on glass slides using ProLong Antifade (Molecular Probes) for fluorescent detection of GFP and cyclin D<sub>1</sub> on an Olympus IX70 microscope at 100 &#x000d7; magnification.</p></sec><sec><title>Podocyte cell-cell contact</title><p>Total RNA and protein were extracted from wild-type, control-infected, and HIV-1 infected podocytes during the Reiser, et al. protocol to study subconfluent podocyte growth and podocyte growth during establishment of mature cell-cell contacts between differentiated podocytes [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. Briefly, RNA and protein were extracted from parallel plates of podocytes using TRIZOL Reagent or RIPA buffer, respectively, under three conditions: 1) during sub-confluent growth at 33&#x000b0;C; 2) immediately upon reaching confluency (day zero); and 3) on day 14 after switching confluent cultures to 37&#x000b0;C. At the end of the differentiation protocol (day 14), additional plates were stained to detect foci formation as follows: cells were washed with 1 &#x000d7; PBS, fixed in methanol for 1 minute, stained with bromophenol blue for 1 minute, then washed again with 1 &#x000d7; PBS. In experiments utilizing the single gene mutant of HIV-1, total RNA was extract from infected podocytes 14 days after switching confluent cultures to 37&#x000b0;C. All experiments were performed twice.</p></sec><sec><title>Flavopiridol treatment</title><p>After the 14-day podocyte differentiation protocol described above, total RNA was extracted from wild-type and HIV-1-infected podocytes before treatment with flavopiridol (Developmental Therapeutics Program, National Cancer Institute) (day 14), two days after suppression of HIV-1 transcription with media containing 50 nM flavopiridol (day 16), and one day after drug washout using media without flavopiridol (day 17). The experiment was performed twice.</p></sec><sec><title>Cyclin D<sub>1</sub> transcript and protein</title><p>RNA and protein samples were analyzed as follows: Podocyte RNA (10 &#x003bc;g) was analyzed by northern blot using probes for HIV-1 <italic>nef-LTR</italic>[<xref ref-type="bibr" rid="B7">7</xref>], mouse cyclin D<sub>1</sub> (cDNA generated by RT-PCR from mouse podocytes and verified by sequence analysis), synaptopodin [<xref ref-type="bibr" rid="B7">7</xref>], and G3PDH. Following 7.5% SDS/PAGE, podocyte protein (20 &#x003bc;g) was analyzed by western blot for cyclin D<sub>1</sub> (ECL detection of a 1:1000 dilution of rabbit anti-cyclin D<sub>1</sub> antibody, Santa Cruz BioTechnology). Protein (250 &#x003bc;g) from the control-infected or HIV-1-infected podocytes on day 14 of the differentiation protocol was also analyzed by western blot for total pRb (ECL detection of a 1:1000 dilution of rabbit anti-Rb, Santa Cruz Biotechnology) and phospho-Rb (Ser780) (ECL detection of a 1:500 dilution of rabbit anti-phospho-Rb (Ser780) antibody binding, Cell Signaling). Protein concentrations were determined using the Bio-Rad Protein Assay (Bio-Rad Laboratories), and blotting of equivalent amounts of protein was confirmed by transient staining of membranes with Ponceau S solution (0.5% Ponceau S/1% acetic acid) and by western blot for &#x003b2;-actin (Chemicon). Signal intensity was calculated using the UN-SCAN-IT gel v4.3 (Silk Scientific).</p></sec></sec><sec><title>Authors' contributions</title><p>P.J.N. conceived and designed the study; performed the immunohistochemistry, immunofluorescence, and western blotting; and drafted the manuscript. M.S. cultured the podocytes and performed the northern blotting. M.H. designed and prepared the single gene mutants of HIV-1. I.H.G. mentored the authors and participated in the study's design and coordination.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank Paul Klotman for the use of podocyte cell-lines, HIV-1 constructs, and Tg26 mice. This work was supported by a National Kidney Foundation Research Award (P.J.N) and by the NIH grant DK 56492&#x02013;02.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>F</given-names></name><name><surname>Adle-Biassette</surname><given-names>H</given-names></name><name><surname>Chretien</surname><given-names>F</given-names></name><name><surname>Lorin de la Grandmaison</surname><given-names>G</given-names></name><name><surname>Force</surname><given-names>G</given-names></name><name><surname>Keohane</surname><given-names>C</given-names></name></person-group><article-title>Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments.</article-title><source>Clin Neuropathol</source><year>2001</year><volume>20</volume><fpage>146</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">11495003</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barbaro</surname><given-names>G</given-names></name><name><surname>Di Lorenzo</surname><given-names>G</given-names></name><name><surname>Grisorio</surname><given-names>B</given-names></name><name><surname>Barbarini</surname><given-names>G</given-names></name></person-group><article-title>Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS.</article-title><source>N Engl J Med</source><year>1998</year><volume>339</volume><fpage>1093</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9770555</pub-id><pub-id pub-id-type="doi">10.1056/NEJM199810153391601</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Janoff</surname><given-names>EN</given-names></name><name><surname>Smith</surname><given-names>PD</given-names></name></person-group><article-title>Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management.</article-title><source>Gastroenterology</source><year>2001</year><volume>120</volume><fpage>607</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">11179239</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shankland</surname><given-names>SJ</given-names></name><name><surname>Eitner</surname><given-names>F</given-names></name><name><surname>Hudkins</surname><given-names>KL</given-names></name><name><surname>Goodpaster</surname><given-names>T</given-names></name><name><surname>D'Agati</surname><given-names>V</given-names></name><name><surname>Alpers</surname><given-names>CE</given-names></name></person-group><article-title>Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.</article-title><source>Kidney Int</source><year>2000</year><volume>58</volume><fpage>674</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">10916090</pub-id><pub-id pub-id-type="doi">10.1046/j.1523-1755.2000.00213.x</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barisoni</surname><given-names>L</given-names></name><name><surname>Mokrzycki</surname><given-names>M</given-names></name><name><surname>Sablay</surname><given-names>L</given-names></name><name><surname>Nagata</surname><given-names>M</given-names></name><name><surname>Yamase</surname><given-names>H</given-names></name><name><surname>Mundel</surname><given-names>P</given-names></name></person-group><article-title>Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies.</article-title><source>Kidney Int</source><year>2000</year><volume>58</volume><fpage>137</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">10886558</pub-id><pub-id pub-id-type="doi">10.1046/j.1523-1755.2000.00149.x</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>EJ</given-names></name><name><surname>Cara</surname><given-names>A</given-names></name><name><surname>Snoeck</surname><given-names>H</given-names></name><name><surname>Ross</surname><given-names>MD</given-names></name><name><surname>Sunamoto</surname><given-names>M</given-names></name><name><surname>Reiser</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes.</article-title><source>J Am Soc Nephrol</source><year>2001</year><volume>12</volume><fpage>1677</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">11461940</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>PJ</given-names></name><name><surname>Gelman</surname><given-names>IH</given-names></name><name><surname>Klotman</surname><given-names>PE</given-names></name></person-group><article-title>Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes.</article-title><source>J Am Soc Nephrol</source><year>2001</year><volume>12</volume><fpage>2827</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">11729253</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Husain</surname><given-names>M</given-names></name><name><surname>Gusella</surname><given-names>GL</given-names></name><name><surname>Klotman</surname><given-names>ME</given-names></name><name><surname>Gelman</surname><given-names>IH</given-names></name><name><surname>Ross</surname><given-names>MD</given-names></name><name><surname>Schwartz</surname><given-names>EJ</given-names></name><etal></etal></person-group><article-title>HIV-1 Nef Induces Proliferation and Anchorage-Independent Growth in Podocytes.</article-title><source>J Am Soc Nephrol</source><year>2002</year><volume>13</volume><fpage>1806</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">12089376</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barisoni</surname><given-names>L</given-names></name><name><surname>Kriz</surname><given-names>W</given-names></name><name><surname>Mundel</surname><given-names>P</given-names></name><name><surname>D'Agati</surname><given-names>V</given-names></name></person-group><article-title>The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy.</article-title><source>J Am Soc Nephrol</source><year>1999</year><volume>10</volume><fpage>51</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">9890309</pub-id><pub-id pub-id-type="doi">10.1159/000017097</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barisoni</surname><given-names>L</given-names></name><name><surname>Bruggeman</surname><given-names>LA</given-names></name><name><surname>Mundel</surname><given-names>P</given-names></name><name><surname>D'Agati</surname><given-names>VD</given-names></name><name><surname>Klotman</surname><given-names>PE</given-names></name></person-group><article-title>HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy.</article-title><source>Kidney Int</source><year>2000</year><volume>58</volume><fpage>173</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">10886562</pub-id><pub-id pub-id-type="doi">10.1046/j.1523-1755.2000.00152.x</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dickie</surname><given-names>P</given-names></name><name><surname>Felser</surname><given-names>J</given-names></name><name><surname>Eckhaus</surname><given-names>M</given-names></name><name><surname>Bryant</surname><given-names>J</given-names></name><name><surname>Silver</surname><given-names>J</given-names></name><name><surname>Marinos</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>HIV-associated nephropathy in transgenic mice expressing HIV-1 genes.</article-title><source>Virology</source><year>1991</year><volume>185</volume><fpage>109</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">1926769</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kopp</surname><given-names>JB</given-names></name><name><surname>Klotman</surname><given-names>ME</given-names></name><name><surname>Adler</surname><given-names>SH</given-names></name><name><surname>Bruggeman</surname><given-names>LA</given-names></name><name><surname>Dickie</surname><given-names>P</given-names></name><name><surname>Marinos</surname><given-names>NJ</given-names></name><etal></etal></person-group><article-title>Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes.</article-title><source>Proc Natl Acad Sci U S A</source><year>1992</year><volume>89</volume><fpage>1577</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">1542649</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bruggeman</surname><given-names>LA</given-names></name><name><surname>Dikman</surname><given-names>S</given-names></name><name><surname>Meng</surname><given-names>C</given-names></name><name><surname>Quaggin</surname><given-names>SE</given-names></name><name><surname>Coffman</surname><given-names>TM</given-names></name><name><surname>Klotman</surname><given-names>PE</given-names></name></person-group><article-title>Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression.</article-title><source>J Clin Invest</source><year>1997</year><volume>100</volume><fpage>84</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">9202060</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>W</given-names></name><name><surname>Sadowska</surname><given-names>M</given-names></name><name><surname>Denaro</surname><given-names>F</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Foulke</surname><given-names>J</given-names><suffix>Jr</suffix></name><name><surname>Hayes</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction.</article-title><source>Proc Natl Acad Sci U S A</source><year>2001</year><volume>98</volume><fpage>9271</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11481487</pub-id><pub-id pub-id-type="doi">10.1073/pnas.161290298</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frankel</surname><given-names>AD</given-names></name><name><surname>Young</surname><given-names>JA</given-names></name></person-group><article-title>HIV-1: fifteen proteins and an RNA.</article-title><source>Annu Rev Biochem</source><year>1998</year><volume>67</volume><fpage>1</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">9759480</pub-id><pub-id pub-id-type="doi">10.1146/annurev.biochem.67.1.1</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lukas</surname><given-names>J</given-names></name><name><surname>Muller</surname><given-names>H</given-names></name><name><surname>Bartkova</surname><given-names>J</given-names></name><name><surname>Spitkovsky</surname><given-names>D</given-names></name><name><surname>Kjerulff</surname><given-names>AA</given-names></name><name><surname>Jansen-Durr</surname><given-names>P</given-names></name><etal></etal></person-group><article-title>DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.</article-title><source>J Cell Biol</source><year>1994</year><volume>125</volume><fpage>625</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">8175885</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ojala</surname><given-names>PM</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name><name><surname>Castanos-Velez</surname><given-names>E</given-names></name><name><surname>Biberfeld</surname><given-names>P</given-names></name><name><surname>Korsmeyer</surname><given-names>SJ</given-names></name><name><surname>Makela</surname><given-names>TP</given-names></name></person-group><article-title>The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2.</article-title><source>Nat Cell Biol</source><year>2000</year><volume>2</volume><fpage>819</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">11056537</pub-id><pub-id pub-id-type="doi">10.1038/35041064</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santoni-Rugiu</surname><given-names>E</given-names></name><name><surname>Falck</surname><given-names>J</given-names></name><name><surname>Mailand</surname><given-names>N</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name><name><surname>Lukas</surname><given-names>J</given-names></name></person-group><article-title>Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.</article-title><source>Mol Cell Biol</source><year>2000</year><volume>20</volume><fpage>3497</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">10779339</pub-id><pub-id pub-id-type="doi">10.1128/MCB.20.10.3497-3509.2000</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frame</surname><given-names>MC</given-names></name><name><surname>Fincham</surname><given-names>VJ</given-names></name><name><surname>Carragher</surname><given-names>NO</given-names></name><name><surname>Wyke</surname><given-names>JA</given-names></name></person-group><article-title>v-Src's hold over actin and cell adhesions.</article-title><source>Nat Rev Mol Cell Biol</source><year>2002</year><volume>3</volume><fpage>233</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">11994743</pub-id><pub-id pub-id-type="doi">10.1038/nrm779</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ekholm</surname><given-names>SV</given-names></name><name><surname>Reed</surname><given-names>SI</given-names></name></person-group><article-title>Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle.</article-title><source>Curr Opin Cell Biol</source><year>2000</year><volume>12</volume><fpage>676</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">11063931</pub-id><pub-id pub-id-type="doi">10.1016/S0955-0674(00)00151-4</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baldin</surname><given-names>V</given-names></name><name><surname>Lukas</surname><given-names>J</given-names></name><name><surname>Marcote</surname><given-names>MJ</given-names></name><name><surname>Pagano</surname><given-names>M</given-names></name><name><surname>Draetta</surname><given-names>G</given-names></name></person-group><article-title>Cyclin D1 is a nuclear protein required for cell cycle progression in G1.</article-title><source>Genes Dev</source><year>1993</year><volume>7</volume><fpage>812</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">8491378</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>W</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>DY</given-names></name><name><surname>Koh</surname><given-names>GY</given-names></name></person-group><article-title>Differential changes of cell cycle regulators and activities in kidneys during pre- and postnatal development.</article-title><source>Nephron</source><year>1999</year><volume>81</volume><fpage>334</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">10050090</pub-id><pub-id pub-id-type="doi">10.1159/000045302</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shankland</surname><given-names>SJ</given-names></name><name><surname>Wolf</surname><given-names>G</given-names></name></person-group><article-title>Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis.</article-title><source>Am J Physiol Renal Physiol</source><year>2000</year><volume>278</volume><fpage>F515</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">10751212</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>M</given-names></name><name><surname>Higashi</surname><given-names>H</given-names></name><name><surname>Jung</surname><given-names>HK</given-names></name><name><surname>Suzuki-Takahashi</surname><given-names>I</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Tamai</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.</article-title><source>Embo J</source><year>1996</year><volume>15</volume><fpage>7060</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9003781</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>PJ</given-names></name><name><surname>Daniel</surname><given-names>TO</given-names></name></person-group><article-title>Emerging targets: Molecular mechanisms of cell contact-mediated growth control.</article-title><source>Kidney Int</source><year>2002</year><volume>61</volume><fpage>99</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">11841621</pub-id><pub-id pub-id-type="doi">10.1046/j.1523-1755.2002.0610s1099.x</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pabst</surname><given-names>R</given-names></name><name><surname>Sterzel</surname><given-names>RB</given-names></name></person-group><article-title>Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis.</article-title><source>Kidney Int</source><year>1983</year><volume>24</volume><fpage>626</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">6663985</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reiser</surname><given-names>J</given-names></name><name><surname>Kriz</surname><given-names>W</given-names></name><name><surname>Kretzler</surname><given-names>M</given-names></name><name><surname>Mundel</surname><given-names>P</given-names></name></person-group><article-title>The glomerular slit diaphragm is a modified adherens junction.</article-title><source>J Am Soc Nephrol</source><year>2000</year><volume>11</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10616834</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mundel</surname><given-names>P</given-names></name><name><surname>Reiser</surname><given-names>J</given-names></name><name><surname>Zuniga Mejia Borja</surname><given-names>A</given-names></name><name><surname>Pavenstadt</surname><given-names>H</given-names></name><name><surname>Davidson</surname><given-names>GR</given-names></name><name><surname>Kriz</surname><given-names>W</given-names></name><etal></etal></person-group><article-title>Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.</article-title><source>Exp Cell Res</source><year>1997</year><volume>236</volume><fpage>248</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">9344605</pub-id><pub-id pub-id-type="doi">10.1006/excr.1997.3739</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>SH</given-names></name><name><surname>Fujinaga</surname><given-names>K</given-names></name><name><surname>Marion</surname><given-names>JE</given-names></name><name><surname>Taube</surname><given-names>R</given-names></name><name><surname>Sausville</surname><given-names>EA</given-names></name><name><surname>Senderowicz</surname><given-names>AM</given-names></name><etal></etal></person-group><article-title>Flavopiridol inhibits P-TEFb and blocks HIV-1 replication.</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>28345</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10906320</pub-id><pub-id pub-id-type="doi">10.1074/jbc.C000446200</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>SH</given-names></name><name><surname>Price</surname><given-names>DH</given-names></name></person-group><article-title>Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo.</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>31793</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11431468</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M102306200</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanna</surname><given-names>Z</given-names></name><name><surname>Weng</surname><given-names>X</given-names></name><name><surname>Kay</surname><given-names>DG</given-names></name><name><surname>Poudrier</surname><given-names>J</given-names></name><name><surname>Lowell</surname><given-names>C</given-names></name><name><surname>Jolicoeur</surname><given-names>P</given-names></name></person-group><article-title>The pathogenicity of human immunodeficiency virus (hiv) type 1 nef in cd4c/hiv transgenic mice is abolished by mutation of its sh3-binding domain, and disease development is delayed in the absence of hck.</article-title><source>J Virol</source><year>2001</year><volume>75</volume><fpage>9378</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">11533201</pub-id><pub-id pub-id-type="doi">10.1128/JVI.75.19.9378-9392.2001</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Penuel</surname><given-names>E</given-names></name><name><surname>Martin</surname><given-names>GS</given-names></name></person-group><article-title>Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways.</article-title><source>Mol Biol Cell</source><year>1999</year><volume>10</volume><fpage>1693</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">10359590</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muise-Helmericks</surname><given-names>RC</given-names></name><name><surname>Grimes</surname><given-names>HL</given-names></name><name><surname>Bellacosa</surname><given-names>A</given-names></name><name><surname>Malstrom</surname><given-names>SE</given-names></name><name><surname>Tsichlis</surname><given-names>PN</given-names></name><name><surname>Rosen</surname><given-names>N</given-names></name></person-group><article-title>Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway.</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>29864</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">9792703</pub-id><pub-id pub-id-type="doi">10.1074/jbc.273.45.29864</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hashemolhosseini</surname><given-names>S</given-names></name><name><surname>Nagamine</surname><given-names>Y</given-names></name><name><surname>Morley</surname><given-names>SJ</given-names></name><name><surname>Desrivieres</surname><given-names>S</given-names></name><name><surname>Mercep</surname><given-names>L</given-names></name><name><surname>Ferrari</surname><given-names>S</given-names></name></person-group><article-title>Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability.</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>14424</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9603954</pub-id><pub-id pub-id-type="doi">10.1074/jbc.273.23.14424</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>PE</given-names></name><name><surname>Bruggeman</surname><given-names>LA</given-names></name><name><surname>Weeks</surname><given-names>BS</given-names></name><name><surname>Kopp</surname><given-names>JB</given-names></name><name><surname>Bryant</surname><given-names>JL</given-names></name><name><surname>Owens</surname><given-names>JW</given-names></name><name><surname>Notkins</surname><given-names>AL</given-names></name><name><surname>Klotman</surname><given-names>PE</given-names></name></person-group><article-title>bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice.</article-title><source>Kidney Int</source><year>1994</year><volume>46</volume><fpage>759</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">7996798</pub-id></citation></ref></ref-list></back></article> 